Branch News

NCI Gives Fine "Lead Role" In Clinical Trials System Review

Howard Fine, chief of the Neuro-Oncology Branch in the NCI Center for Cancer Research, will serve as head of the Institute-selected committee to study the clinical trials system, sources said.

NCI Director Andrew von Eschenbach mentioned Fine in the last paragraph of his weekly “Director’s Update." “Improving the speed and efficiency with which cancer clinical trials are conducted will be an important priority for NCI over the coming years,” von Eschenbach wrote in his Nov. 11 column.

“Drs. James H. Doroshow and Howard Fine will be taking the lead role in this effort. “NCI is now formulating a large-scale initiative aimed at developing
and deploying an integrated clinical trials system to accelerate the development of interventions and ensure that those interventions are efficiently incorporated into the care of all who need them,” von Eschenbach continued. “We will continue to keep you informed about this effort. ”